Abstract
Cardiac resynchronization therapy (CRT) is a well-accepted and effective therapy for treating patients with a wide QRS complex, significant left ventricular systolic dysfunction, and symptoms of advanced heart failure. However, approximately 25% to 30% of patients fail to respond to this therapy. Most large studies have used electrical dyssynchrony (wide QRS) as a main entrance criterion. Emerging data suggest that mechanical dyssynchrony may be a more important factor in selecting appropriate candidates for CRT. New echocardiographic (ECHO) imaging modalities such as tissue Doppler imaging, three-dimensional ECHO, and speckle tracking ECHO are able to quantify left ventricular mechanical dyssynchrony. These techniques are currently being used to assist in the selection of patients for CRT. Recently published and ongoing studies are addressing the use of CRT in patients who do not meet the standard criteria, such as patients with atrial fibrillation, mild to moderate heart failure, narrow QRS complex, and acute myocardial infarction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.